Endologix (ELGXQ) Stock Price, News & Analysis

Company Overview

Endologix, Inc. was a medical device company focused on developing, manufacturing and marketing minimally invasive technologies for the treatment of aortic disorders, particularly abdominal aortic aneurysms (AAAs). Its products were designed to support endovascular aneurysm repair, a less invasive alternative to open surgical procedures.

The company’s product portfolio included the AFX Endovascular AAA System, the Ovation Abdominal Stent Graft System and the Alto Abdominal Stent Graft System. These devices used stent grafts to help reinforce weakened sections of the aorta and redirect blood flow away from an aneurysm.

Endologix was based in Irvine, California, and historically served hospitals and vascular specialists in the United States and international markets. The company filed for Chapter 11 bankruptcy protection in 2021, and its publicly traded securities subsequently traded under the ELGXQ symbol. Information about its current operations and leadership is limited.

Key Stats

• Today's Range: $0.0199 to $0.0199
• 50-Day Range: $0.0199 to $0.0199
• 52-Week Range: $0.01 to $3.96
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/16/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:ELGXQ
• CIK: N/A
• Web: www.endologix.com
• Phone: 949-595-7200
• Fax: 949-699-9622
• Employees: 528
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A